N/A Completed N=107 Randomized Double-blind Treatment

DD T2 Daily Disposable Registration Trial

Myopia · Refractive errors

Source: ClinicalTrials.gov NCT03305770 ↗

Enrolled (actual)

107

Serious AEs

0.0%

Results posted

Feb 2019

Primary outcomePrimary: Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen) — 74; 32; 62; 40 eyes

Summary

The purpose of this study is to evaluate the performance of the investigational verofilcon A contact lens compared to the commercially available delefilcon A contact lens, by assessing visual acuity as the primary variable.

Outcome Measures

Outcome	Result	p-value
PRIMARY Monocular Visual Acuity (VA) With Contact Lenses at Each Visit (Snellen)	74; 32; 62; 40; 2; 0	—

Eligibility Criteria

Inclusion Criteria

Successful wear of spherical soft contact lenses for distance correction in both eyes during the past 3 months for a minimum of 5 days per week and 8 hours per day.
Best corrected VA 20/25 or better in each eye.
Other protocol-specified inclusion criteria may apply.

Exclusion Criteria

Any current or prior wear experience with DT1 lenses.
Wearing habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week) over the last 3 months prior to enrollment.
Other protocol-specified exclusion criteria may apply.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03305770). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.